Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 381,626 | 425,999 | 440,927 | 453,906 | 415,418 |
| Marketable Securities | 97,861 | 197,824 | 135,442 | 158,613 | 220,445 |
| Receivables | 6,275 | 68,644 | 79 | 2,680 | 1,479 |
| Inventories | 7,339 | 524 | 230 | N/A | N/A |
| Income taxes - deferred | N/A | 8,771 | N/A | N/A | N/A |
| Other current assets | 66,385 | 0 | 62,464 | 54,735 | 48,240 |
| TOTAL | $562,190 | $708,814 | $645,967 | $676,897 | $692,643 |
| Non-Current Assets | |||||
| PPE Net | 126,807 | 108,588 | 92,981 | 57,807 | 51,241 |
| Investments And Advances | 396,924 | 252,051 | 264,105 | 218,236 | 154,043 |
| Other Non-Current Assets | 96,001 | 71,763 | 0 | 0 | 0 |
| TOTAL | $619,732 | $432,402 | $357,086 | $276,043 | $205,284 |
| Total Assets | $1,181,922 | $1,141,216 | $1,003,053 | $952,940 | $897,927 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,706 | 3,866 | 1,726 | 1,547 | 1,503 |
| Accrued Expenses | 23,489 | 27,616 | 20,369 | 18,412 | 18,477 |
| TOTAL | $28,708 | $33,789 | $22,445 | $21,544 | $23,404 |
| Non-Current Liabilities | |||||
| Long Term Debt | 137,764 | 135,977 | 134,193 | 132,409 | 130,626 |
| Deferred Revenues | 2,513 | 2,307 | 350 | 1,440 | 3,051 |
| aiOther Non-Current Liabilities | 2,573 | 12,118 | 0 | 0 | 0 |
| TOTAL | $143,497 | $150,948 | $144,668 | $142,731 | $140,664 |
| Total Liabilities | $172,205 | $184,737 | $167,113 | $164,275 | $164,068 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 152,218 | 152,958 | 152,508 | 151,908 | 149,243 |
| Common Shares | 77 | 76 | 76 | 76 | 74 |
| Retained earnings | 144,759 | 115,086 | 86,344 | 59,387 | 34,234 |
| Other shareholders' equity | -238 | 1,085 | 1,920 | 828 | 918 |
| TOTAL | $1,009,717 | $956,479 | $835,940 | $788,665 | $733,859 |
| Total Liabilities And Equity | $1,181,922 | $1,141,216 | $1,003,053 | $952,940 | $897,927 |